Monday, June 29, 2026

Muscle Loss May Start in the Brain, Not the Body, Researchers Say

A study reveals that age-related muscle loss may originate from brain dysfunction, suggesting new therapies targeting the dopamine system.

Camera, Action, Kim: Why the ‘Supreme Leader’ is Addicted to the Spotlight

Kim Jong Un engaged in 25 public activities in March, highlighting his hands-on leadership and military focus amid increased propaganda.

Wegovy, Mounjaro Boom Creates New Winners as Ursa, InBody Ride GLP-1 Ripple Effects

GLP-1 obesity drugs are boosting gallstone prevention therapies and body composition monitoring, creating new market opportunities.

Tag: LegoChem Biosciences

LegoChem expands options beyond early ADC licensing into late-stage clinical development

LegoChem Biosciences secures funding to advance ADC therapies into late-stage trials, enhancing strategic flexibility in biotech.

Top News

- Our Sponsors Ad -

Follow us